Huijie F. Wang
No. 270 Dong An Road
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
68Ga-granzyme B (68Ga-NOTA-GSI) PET/CT for predicting immunotherapy response and progression free survival in NSCLC.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 09, 2026
Precision palliative care in advanced/recurrent esophageal cancer patients treated with anti-PD-1/PD-L1 immunotherapy (ESO-Shanghai 25): a randomized, phase III Trial.
Journal: Future oncology (London, England)
Published: March 04, 2026
B3GNT3 facilitates NFKB2 processing and non-canonical NF-κB activation to drive lung adenocarcinoma progression.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 06, 2026
Amivantamab plus chemotherapy vs. chemotherapy as first-line treatment in Chinese mainland patients with EGFR exon 20 insertion non-small cell lung cancer: Subgroup analysis of the randomized PAPILLON trial.
Journal: Chinese medical journal
Published: August 12, 2025
Real-world outcomes of trastuzumab deruxtecan as second- or further-line treatment in patients with HER2-mutant metastatic non-small cell lung cancer: a retrospective study.
Journal: Translational lung cancer research
Published: August 06, 2025
Evaluation of gefitinib alone or combined with bevacizumab in patients with EGFR L858R-positive advanced non-squamous non-small cell lung cancer: an open-label, randomized, phase 2 trial (BEVA-FLFX-001) with exploratory analysis of plasma biomarkers.
Journal: Translational lung cancer research
Published: May 08, 2025
Desmoid fibromatosis with CTNNB1 exon 3 deletion-inversion complex mutation: report of a case
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: March 03, 2025
Small extracellular vesicle miRNAs as biomarkers for predicting antitumor efficacy in lung adenocarcinoma treated with chemotherapy and checkpoint blockade.
Journal: Frontiers in immunology
Published: February 08, 2025
Maintenance therapy for metastatic non-squamous non-small cell lung cancer: efficacy and biomarker analysis of pemetrexed discontinuation.
Journal: Translational lung cancer research
Published: January 05, 2025
Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation.
Journal: Cell reports. Medicine
Published: October 09, 2024
EGFR inhibitors plus dabrafenib and trametinib in patients with EGFR-mutant lung cancer and resistance mediated by BRAFV600E mutation: a multi-center real-world experience in China.
Journal: Translational lung cancer research
Published: September 04, 2024
Last Updated: 09/26/2026